[Immunological treatment of digitalis poisoning with heterologous antibodies].
Our own experience with the production of digoxin-specific antibody preparations from the sheep and the results of the experimental and clinical use are briefly reviewed. Advantages, risks and unsolved problems of therapy with glycoside-specific antibodies are discussed.
D000818:Animals; D000910:Antibodies, Heterophile / Q000008:administration & dosage*; D003327:Coronary Disease / Q000188:drug therapy; D004071:Digitalis Glycosides / Q000506:poisoning*; D004077:Digoxin / Q000276:immunology / Q000506:poisoning; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D007799:Lanatosides / Q000506:poisoning; D011817:Rabbits; D012756:Sheep
D000910:Antibodies, Heterophile; D004071:Digitalis Glycosides; D007799:Lanatosides; D004077:Digoxin
Immunologische Behandlung der Digitalis-Intoxikation mit heterologen Antikörpern.